Axillary hyperhidrosis is characterized by excessive sweating, primarily in the armpits. Axillary hyperhidrosis arises due to genetic causes or physical and emotional stress and family history exists in approximately 30% of the cases. According to American Academy of Dermatology, Axillary hyperhidrosis affects 3% of the population in the U.S. Axillary hyperhidrosis begins in the childhood or in adolescence.
Even though Axillary hyperhidrosis is primarily a physical burden, it may deteriorate quality of life by affecting work and social life and causes significant physiological distress. Patients with axillary hyperhidrosis sweat five times the amount needed to regulate body temperature. However, treatment for axillary hyperhidrosis is readily available and involves topical oral as well as surgical treatment. Choice of treatment depends on severity and affordability, as majority of treatment do not involve reimbursement except surgical treatment. Under CMS (Center for Medicare and Medicaid Services) only 3 treatments with Botulinum toxin A are reimbursed in a year.
Topical treatment with antiperspirant solutions such as Driclor (aluminium chloride hexahydrate), corticosteroid creams etc. are recommended in mild cases. Subcutaneous injection of Botulinum toxin A is recommended in severe cases. Endoscopic thoracic sympathectomy (ETS) is rarely recommended due to less effectiveness of treatment and availability of better alternatives.
Request Sample PDF Brochure:
https://www.futuremarketinsights.com/reports/brochure/rep-gb-6026
Axillary Hyperhidrosis Market: Drivers and Restraints
Global axillary hyperhidrosis is the common condition and can tend to chronic condition. However, the severity diminishes in the older adult life. Growing prevalence of axillary hyperhidrosis is the primary factor driving the growth of the global market. According to International Hyperhidrosis Society study results, 2.8% of the U.S. population is affected with primary hyperhidrosis and over 50% of them suffer from axillary hyperhidrosis.
However, low treatment rate and limited reimbursement are the factors expected to limit the growth of global axillary hyperhidrosis treatment market over the forecast period of 2017-2027. According to survey results from International Hyperhidrosis Society, only 38% of the patients visited their healthcare professionals for their excessive sweating problem.
Axillary Hyperhidrosis Market: Overview
On the basis of treatment, topical treatment segment is expected to contribute high revenue share to global axillary hyperhidrosis treatment. Among oral medications for axillary hyperhidrosis treatment, anticholinergic tablets are most frequently prescribed.
Emerging new techniques such as non-surgical microwave energy destruction of sweat glands using miraDry technology would further flourish the volume for axillary hyperhidrosis treatment market over the forecast period of 2017–2027. Many other treatment procedures are being studied in the clinical trials, which are expected to launch during the forecast period. For instance, Ulthera, Inc. is evaluating Ulthera system – a microfocused ultrasound system for destruction of sweat glands. Candela Corp. in collaboration with is developing diode laser treatment device for axillary hyperhidrosis treatment Success of these treatment options depends on the acceptance by the physicians and adoption of treatment by patients.
Axillary Hyperhidrosis Market: Regional Overview
Geographically, the global axillary hyperhidrosis treatment market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to lead the global axillary hyperhidrosis market due to high prevalence. In 2014, 1.3 Mn population in the U.S. was suffering from axillary hyperhidrosis in the U.S. Moreover, extensive clinical trials in the region would further accelerate the market growth. Asia Pacific axillary hyperhidrosis market is expected to witness delayed growth due to lack of knowledge on advanced treatment options
Inquire Before Buying Research Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-6026
Axillary Hyperhidrosis Market: Key Players
Some of the key players identified in global axillary hyperhidrosis market are GlaxoSmithKline Plc., Allergan Inc. Miramar Labs, Inc., Ulthera, Inc., Candela Corp., Dr. August Wolff GmbH & Co. KG Arzneimittel, Nuvisan GmbH, FGK Clinical Research GmbH, etc. among others.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, ASEAN, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC Countries, S. Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Read Related Reports:
https://acatpg.mn.co/posts/25694272?utm_source=manual
https://globalsocials.mn.co/posts/25694274?utm_source=manual
https://faceblox.mn.co/posts/25694275?utm_source=manual
https://drujrake.mn.co/posts/25694278?utm_source=manual
https://cipmo-system.mn.co/posts/25694281?utm_source=manual
https://globalsocials.mn.co/posts/25694282?utm_source=manual
About Us
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com